Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Different Suppliers

NCT01412281 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

440

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Virosomal influenza vaccine (AdImmune HA Antigen)
BIOLOGICAL: Virosomal influenza vaccine (CSL HA Antigen)

Sponsor

Crucell Holland BV